Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Shaw

Showing results (231-240 of 319) with videos related to

Pageof 32
Sort By:
Neuropharmacology|December 19, 2003
Subtype-selective GABAergic drugs facilitate extinction of mouse operant behaviourCiara McCabe, David Shaw, John R Atack, et al.
Journal of the Intensive Care Society|September 3, 2024
When is directed deceased donation justified? Practical, ethical, and legal issuesDavid Shaw, Dale Gardiner, Rutger Ploeg, et al.
Hepatology (Baltimore, Md.)|June 17, 2008
Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis CStuart K Roberts, Graham Cooksley, Gregory J Dore, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
Cutting Edge: IL-1 receptor-associated kinase 4 structures reveal novel features and multiple conformationsAndreas Kuglstatter, Armando G Villaseñor, David Shaw, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 11, 2018
Euthanasia through living organ donation: Ethical, legal, and medical challengesJan A M Bollen, David Shaw, Guido de Wert, et al.
BMJ Open|January 1, 2020
AMEND study protocol: a case-control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adultsHelen Marshall, Mark McMillan, Bing Wang, et al.
Biotechnology Progress|January 28, 2017
Taming hyperactive hDNase I: Stable inducible expression of a hyperactive salt- and actin-resistant variant of human deoxyribonuclease I in CHO cellsCynthia Lam, Lydia Santell, Blair Wilson, et al.
The Journal of Experimental Medicine|April 22, 2022
High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNASoyoung A Oh, Kate Senger, Shravan Madireddi, et al.
Ticks and Tick-Borne Diseases|July 7, 2021
A multi-seasonal study investigating the phenology, host and habitat associations, and pathogens of Haemaphysalis longicornis in Virginia, U.S.AAlec T Thompson, Seth A White, David Shaw, et al.
Biotechnology Progress|November 21, 2015
Slashing the timelines: Opting to generate high-titer clonal lines faster via viability-based single cell sortingShahram Misaghi, David Shaw, Salina Louie, et al.
Pageof 32

Showing results (231-240 of 319) with videos related to

Sort By:
Pageof 32
Neuropharmacology|December 19, 2003
Subtype-selective GABAergic drugs facilitate extinction of mouse operant behaviourCiara McCabe, David Shaw, John R Atack, et al.
Journal of the Intensive Care Society|September 3, 2024
When is directed deceased donation justified? Practical, ethical, and legal issuesDavid Shaw, Dale Gardiner, Rutger Ploeg, et al.
Hepatology (Baltimore, Md.)|June 17, 2008
Robust antiviral activity of R1626, a novel nucleoside analog: a randomized, placebo-controlled study in patients with chronic hepatitis CStuart K Roberts, Graham Cooksley, Gregory J Dore, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
Cutting Edge: IL-1 receptor-associated kinase 4 structures reveal novel features and multiple conformationsAndreas Kuglstatter, Armando G Villaseñor, David Shaw, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 11, 2018
Euthanasia through living organ donation: Ethical, legal, and medical challengesJan A M Bollen, David Shaw, Guido de Wert, et al.
BMJ Open|January 1, 2020
AMEND study protocol: a case-control study to assess the long-term impact of invasive meningococcal disease in Australian adolescents and young adultsHelen Marshall, Mark McMillan, Bing Wang, et al.
Biotechnology Progress|January 28, 2017
Taming hyperactive hDNase I: Stable inducible expression of a hyperactive salt- and actin-resistant variant of human deoxyribonuclease I in CHO cellsCynthia Lam, Lydia Santell, Blair Wilson, et al.
The Journal of Experimental Medicine|April 22, 2022
High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNASoyoung A Oh, Kate Senger, Shravan Madireddi, et al.
Ticks and Tick-Borne Diseases|July 7, 2021
A multi-seasonal study investigating the phenology, host and habitat associations, and pathogens of Haemaphysalis longicornis in Virginia, U.S.AAlec T Thompson, Seth A White, David Shaw, et al.
Biotechnology Progress|November 21, 2015
Slashing the timelines: Opting to generate high-titer clonal lines faster via viability-based single cell sortingShahram Misaghi, David Shaw, Salina Louie, et al.
Pageof 32